Allergy
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you your search results in order of date.
18986 records returned
Sweet! Sugared Polymer a New Weapon Against Allergies and Asthma-11/19/09
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks. Their advance is a significant step toward crafting pharmaceuticals to fight these often life-endangering conditions in a new way. (Source: Johns Hopkins Medicine News)
Source: Johns Hopkins Medicine News - November 21, 2009 Category: Research Source Type: news
Circassia Announces Successful Results From Phase II Clinical Study Of ToleroMune(R) Cat Allergy TherapyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, announced positive results from a recently completed phase II clinical study of its ToleroMune(R) cat allergy therapy, which successfully identified the optimal dosing regimens to progress into late-stage development. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 21, 2009 Category: Consumer Health News Tags: allergy Source Type: news
Circassia Announces Successful Results From Phase II Clinical Study Of ToleroMune(R) Cat Allergy TherapyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, announced positive results from a recently completed phase II clinical study of its ToleroMune(R) cat allergy therapy, which successfully identified the optimal dosing regimens to progress into late-stage development. (Source: Allergy News From Medical News Today)
Source: Allergy News From Medical News Today - November 21, 2009 Category: Allergy & Immunology Tags: allergy Source Type: news
FDA Advisory Committee Finds Data Support The Claim That SPIRIVA(R) HandiHaler(R) Reduces COPD ExacerbationsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee voted 11 to 1 that clinical data included in a supplemental new drug application (sNDA) provide substantial and convincing evidence to support the claim that SPIRIVA® HandiHaler® (tiotropium bromide inhalation powder) reduces exacerbations (worsening of symptoms) in patients with chronic obstructive pulmonary disease (COPD). (Source: Asthma / Respiratory News From Medical News Today)
Source: Asthma / Respiratory News From Medical News Today - November 21, 2009 Category: Respiratory Medicine Tags: COPD Source Type: news
Does gastric acid suppression increase the risk of drug allergies?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Clinical and Experimental Allergy)
Source: Clinical and Experimental Allergy - November 21, 2009 Category: Allergy & Immunology Authors: C. Pickard, A. P. Sampson Source Type: journals
Recommendations for assessing Patient-Reported Outcomes and Health-Related quality of life in clinical trials on allergy: a GA2LEN taskforce position paperEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The aim of this Global Allergy and Asthma European Network (GA2LEN) consensus report is to provide recommendations for patient-reported outcomes (PROs) evaluation in clinical trials for allergic diseases, which constitute a global health problem in terms of physical, psychological economic and social impact. During the last 40 years, PROs have gained large consideration and use in the scientific community, to gain a better understanding of patients' subjective assessment with respect to elements concerning their health condition. They include all health-related reports coming from the patient, without involvement or interp...
Source: Allergy - November 21, 2009 Category: Allergy & Immunology Authors: I. Baiardini, P. J. Bousquet, Z. Brzoza, G. W. Canonica, E. Compalati, A. Fiocchi, W. Fokkens, R. G. van Wijk, S. La Grutta, C. Lombardi, M. Maurer, A. M. Pinto, E. Ridolo, G. E. Senna, I. Terreehorst, A. Todo Bom, J. Bousquet, T. Zuberbier, F. Braido Source Type: journals
Sweet! Sugared Polymer A New Weapon Against Allergies And AsthmaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks. Their advance is a significant step toward crafting pharmaceuticals to fight these often life-endangering conditions in a new way. For more than a decade, a team led by Bruce S. Bochner, M.D. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 20, 2009 Category: Consumer Health News Tags: allergy Source Type: news
Sweet! Sugared Polymer A New Weapon Against Allergies And AsthmaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks. Their advance is a significant step toward crafting pharmaceuticals to fight these often life-endangering conditions in a new way. For more than a decade, a team led by Bruce S. Bochner, M.D. (Source: Allergy News From Medical News Today)
Source: Allergy News From Medical News Today - November 20, 2009 Category: Allergy & Immunology Tags: allergy Source Type: news
Superior Foods Co. Issues Allergy Alert On Undeclared Allergens in Fish ProductEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Superior Foods Co., Grand Rapids, MI. is recalling Lemon Pepper Marinated Catfish because it may contain undeclared soy and FD&C Yellow #5. In addition, Superior Foods Co. is recalling Cajun Style Marinated Catfish because it may contain soy and milk that is not declared on the label. People who have an allergy or severe sensitivity to these run the risk of serious or life-threatening allergic reaction if they consume these products. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 20, 2009 Category: Food Science Source Type: organizations
Thanksgiving Meal Tips for People With Food Allergies or DiabetesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
It's OK to indulge a bit if you have diabetes, but advance preparation is key. (Source: U.S. News - Health)
Source: U.S. News - Health - November 20, 2009 Category: Consumer Health News Source Type: consumer
QUESTION 1. Normal CSF: does it exclude meningitis?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Archives of Disease in Childhood)
Source: Archives of Disease in Childhood - November 20, 2009 Category: Pediatrics Authors: Ray, B., Rylance, G. Tags: ADC Archimedes, Epidemiologic studies, Immunology (including allergy), Drugs: infectious diseases, Meningitis, Vaccination / immunisation, Infection (neurology), Child health, Infant health, Neonatal health Source Type: journals
Evaluating adherence to medication in children and adolescents with HIVEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion:
In our study, pharmacy supply was not associated with self-reported adherence. Most importantly, adherence and age were significant predictors of reaching undetectable viral loads. (Source: Archives of Disease in Childhood)
Source: Archives of Disease in Childhood - November 20, 2009 Category: Pediatrics Authors: Khan, M, Song, X, Williams, K, Bright, K, Sill, A, Rakhmanina, N Tags: Epidemiologic studies, Immunology (including allergy), HIV/AIDS, Adolescent health, Child health, Sexual health Drug therapy Source Type: journals
Comparison of morphine concentration-time profiles following intravenous and intranasal diamorphine in childrenEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions:
Our evidence supports the wider use of diamorphine administration by nasal drops in children, as it shows that adequate plasma levels of morphine are usually achieved. However, we demonstrated significantly attenuated and delayed peak plasma morphine levels with lower levels at 1 h with intranasal compared with intravenous diamorphine. (Source: Archives of Disease in Childhood)
Source: Archives of Disease in Childhood - November 20, 2009 Category: Pediatrics Authors: Kidd, S, Brennan, S, Stephen, R, Minns, R, Beattie, T Tags: Immunology (including allergy), Pain (neurology), Pain (palliative care), Pain (anaesthesia) Drug therapy Source Type: journals
Regionally acquired intestinal failure data suggest an underestimate in national service requirementsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions:
Survival for IF at 56% was lower than reported from non-UK supra-regional centres, and nationally collected data, possibly reflecting pre-selected referral populations. Data from regional centres with complete ascertainment may be important both when counselling parents and when planning regional and national HPN and IF specialist services. (Source: Archives of Disease in Childhood)
Source: Archives of Disease in Childhood - November 20, 2009 Category: Pediatrics Authors: Barclay, A R, Paxton, C E, Gillett, P, Hoole, D, Livingstone, J, Young, D, Menon, G, Munro, F, Wilson, D C Tags: Liver disease, Epidemiologic studies, Immunology (including allergy), Childhood nutrition, Childhood nutrition (paediatrics), Child health, Artificial and donated transplantation Original articles Source Type: journals
FDA Panel Finds Tiotropium Safe for COPD PatientsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
An FDA committee said new data allay concerns about the risk of stroke and cardiovascular events previously associated with tiotropium (Spiriva), drugmaker Boehringer Ingelheim said. (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - November 20, 2009 Category: Allergy & Immunology Source Type: news
Beta-2 Receptor Variants Don't Affect LABA Response in Asthma (CME/CE)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Against expectations, asthma patients with different genotypes for the beta-2 adrenergic receptor all responded well to long-acting beta agonist (LABA) asthma drugs, researchers said. (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - November 20, 2009 Category: Allergy & Immunology Source Type: news
Ecallantide Effective for Acute Episodes of Hereditary AngioedemaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The investigational plasma kallikrein inhibitor ecallantide achieves rapid and sustained symptom relief from acute episodes of hereditary angioedema. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 20, 2009 Category: Consumer Health News Tags: allergy & Clinical Immunology Source Type: news
A new weapon against allergies and asthmaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Researchers at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks. Their advance is a significant step toward crafting pharmaceuticals to fight these often life-endangering conditions in a new way........ (Source: Medicineworld.org: New Article Alert)
Source: Medicineworld.org: New Article Alert - November 20, 2009 Category: Consumer Health News Source Type: info
Fresh & Easy Neighborhood Market Issues Allergy Alert on Undeclared Pecans in Mislabeled Fresh & Easy Pumpkin Cheesecake PiesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
– Fresh & Easy Neighborhood Market is voluntarily recalling some fresh&easy™ “Pumpkin Cheesecake Pies” (40 oz.) because they may contain undeclared pecans. Individuals who have allergies to pecans run the risk of serious or life-threatening allergic reaction if they consume these products. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 20, 2009 Category: Food Science Source Type: organizations
Potential Strategy To Help Generate HIV-Neutralizing AntibodiesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WHAT: New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 20, 2009 Category: Consumer Health News Tags: HIV / AIDS Source Type: news
Potential Strategy To Help Generate HIV-Neutralizing AntibodiesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WHAT: New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. (Source: Immune System / Vaccines News From Medical News Today)
Source: Immune System / Vaccines News From Medical News Today - November 20, 2009 Category: Allergy & Immunology Tags: HIV / AIDS Source Type: news
Investigation of incidental hypercalcaemiaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: BMJ Online First)
Source: BMJ Online First - November 20, 2009 Category: Journals (General) Authors: Joshi, D., Center, J. R, Eisman, J. A Tags: Neurogastroenterology, Infectious diseases, Urology, Immunology (including allergy), Pain (neurology), Endocrine cancer, Musculoskeletal syndromes, Urological surgery, Calcium and bone, Metabolic disorders, Thyroid disease PRACTICE Source Type: journals
EFA Highlights The Urgent Need For Change And A Comprehensive European Strategy To Fight Chronic Obstructive Pulmonary DiseaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The European Federation of Allergy and Airways Diseases Patients Associations (EFA) today launched a book comparing and analysing the situation of Chronic Obstructive Pulmonary Disease (COPD) in Europe for the first time from the patients' perspective. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 20, 2009 Category: Consumer Health News Tags: COPD Source Type: news
EFA Highlights The Urgent Need For Change And A Comprehensive European Strategy To Fight Chronic Obstructive Pulmonary DiseaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The European Federation of Allergy and Airways Diseases Patients Associations (EFA) today launched a book comparing and analysing the situation of Chronic Obstructive Pulmonary Disease (COPD) in Europe for the first time from the patients' perspective. The Book highlights and urgent need to reduce the suffering and mortality from this disease, which will - if not tackled appropriately - be the third leading cause of death worldwide by 2030. (Source: Asthma / Respiratory News From Medical News Today)
Source: Asthma / Respiratory News From Medical News Today - November 20, 2009 Category: Respiratory Medicine Tags: COPD Source Type: news
Discovery of new type of immune cells regulating inflammation in chronic diseasesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Helmholtz Zentrum München - German Research Center for Environmental Health) Scientists of Helmholtz Zentrum Muenchen and the Center of Allergy and Environment of Technische Universitaet Muenchen have discovered a new type of immune cells -- the Th22 cells -- which can protect the body against inflammation and aid in tissue repair. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 20, 2009 Category: Global & Universal Source Type: news
Food, environmental allergies pose threat to childrenEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
When introducing your newborn to new foods, be sure to look out for signs of food allergies, said an expert at Baylor College of Medicine . "Food allergies can occur in babies as young as six months old," said Dr. Carla Davis, assistant professor of pediatrics - allergy and immunology at BCM. There are eight foods that cause 90 percent of allergies in kids, said Davis. These include: Cow's milk Eggs Soy beans Wheat Tree nuts Peanuts Fish and shellfish Introduce foods one at a time Davis, who sees patients at Texas Children's Hospital, emphasizes the importance of introducing one food at a time to infants, so it i...
Source: Baylor College of Medicine News - November 20, 2009 Category: Universities & Medical Training Source Type: news
Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScoresEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions These new algorithms can predict risk of fracture in primary care populations in the UK without laboratory measurements and are therefore suitable for use in both clinical settings and for self assessment (www.qfracture.org). QFractureScores could be used to identify patients at high risk of fracture who might benefit from interventions to reduce their risk. (Source: BMJ Online First)
Source: BMJ Online First - November 20, 2009 Category: Journals (General) Authors: Hippisley-Cox, J., Coupland, C. Tags: Liver disease, Smoking and tobacco, Epidemiologic studies, General practice / family medicine, Immunology (including allergy), Drugs: cardiovascular system, Menopause (including HRT), Asthma, Connective tissue disease, Degenerative joint disease, Drugs: m Source Type: journals
The economy-wide impact of pandemic influenza on the UK: a computable general equilibrium modelling experimentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion Balancing school closure against "business as usual" and obtaining sufficient stocks of effective vaccine are more important factors in determining the economic impact of an influenza pandemic than is the disease itself. Prophylactic absence from work in response to fear of infection can add considerably to the economic impact. (Source: BMJ Online First)
Source: BMJ Online First - November 20, 2009 Category: Journals (General) Authors: Smith, R. D, Keogh-Brown, M. R, Barnett, T., Tait, J. Tags: Infectious diseases, Epidemiologic studies, Immunology (including allergy) RESEARCH Source Type: journals
The economic impact of pandemic influenzaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: BMJ Online First)
Source: BMJ Online First - November 20, 2009 Category: Journals (General) Authors: Maynard, A., Bloor, K. Tags: Infectious diseases, Health policy, Immunology (including allergy), Pain (neurology), Adult intensive care, Health economics, Health service research EDITORIALS Source Type: journals
Egg white specific IgE levels in serum as clinical reactivity predictors in the course of egg allergy follow-upEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Montesinos E, Martorell A, Félix R, Cerdá JC. Egg white specific IgE levels in serum as clinical reactivity predictors in the course of egg allergy follow-up.Pediatr Allergy Immunol 2009.© 2009 John Wiley & Sons A/S It is thought that the natural evolution of egg allergy has a good tolerance prognosis. However, there are few follow-up studies that determine the exact probability of tolerance. The aim of this study was to determine the likelihood that children younger than 2,5 years of age with allergy to egg would eventually have tolerance to it and to analyze if monitoring egg white[ndash]specific IgE level over time c...
Source: Pediatric Allergy and Immunology - November 20, 2009 Category: Allergy & Immunology Authors: Elena Montesinos, Antonio Martorell, Rubén Félix, Juan Carlos Cerdá Source Type: journals
FDA Advisory Committee Finds Data Support SPIRIVA® HandiHaler®Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee voted 11 to 1 that clinical data included in a supplemental new drug application (sNDA) provide substantial and convincing evidence to support the claim that SPIRIVA® HandiHaler® (tiotropium bromide inhalation powder) reduces exacerbations (worsening of symptoms) in patients with chronic obstructive pulmonary disease (COPD). (Source: World Pharma News)
Source: World Pharma News - November 20, 2009 Category: Pharmaceuticals Source Type: news
Anaphylaxis to patent blue V: a case series and proposed diagnostic protocolEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Patent blue V is widely used in the identification of sentinel lymph nodes in patients with breast cancer and other malignancies. Individual case reports of allergy to patent blue V have been described in the medical literature since the 1960s. However, there is little data on clinical features and little experience of which allergy tests are appropriate or useful. We gathered all cases of patent blue V allergy that had been seen and diagnosed in the Department of Allergy, Addenbrooke's Hospital over a 3-year period. We collected clinical details of each case including skin test results. For comparison we recruited 12 heal...
Source: Allergy - November 20, 2009 Category: Allergy & Immunology Authors: R. A. Haque, A. Wagner, J. A. Whisken, S. M. Nasser, P. W. Ewan Source Type: journals
Matrix metalloproteinases, IL-8 and glutathione in the prognosis of workers exposed to chlorineEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion: Although no accelerated loss in FEV1 was documented in these workers exposed to chlorine, subjects with a greater fall in FEV1 were more likely to report cough and have higher levels of total glutathione at Vb. (Source: Allergy)
Source: Allergy - November 20, 2009 Category: Allergy & Immunology Authors: K. Maghni, J.-L. Malo, J. L'Archevêque, L. Castellanos, D. Gautrin Source Type: journals
FDA panel rejects omalizumab (Xolair®) for treatment of asthma in children aged 6 to 11Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Reuters Health News
Area: News
An advisory panel to the FDA has voted 10 to 4 against approval of omalizumab (Xolair®) for the treatment of asthma in children aged 6 to 11 years. The committee was split evenly on the effectiveness of the drug but voted by 9 to 5 that its safety record had not been adequately assessed. A member of the FDA's pulmonary and allergy products division told the meeting that while the drug had met its targets in clinical trials, its effectiveness in children was "invariably small and clinically modest." A decision by the FDA on this proposed paediatric use is expected in January 2010. Th...
Source: NeLM - News - November 20, 2009 Category: Drugs & Pharmacology Source Type: organizations
New Findings Suggest Strategy to Help Generate HIV-Neutralizing AntibodiesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
"New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
"Scientists know that an HIV-neutralizing antibody called b12 binds to gp120, an HIV surface protein, at one of the few areas of the virus that does not mutate: the site where gp120 initially attaches to human immune cells. It was thought that exposing the human immune system to this site on gp120 would generate ant...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - November 20, 2009 Category: Infectious Diseases Source Type: info
Comparative resistance of food proteins to adult and infant in vitro digestion modelsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
IgE-mediated allergy to milk and egg is widespread in industrialised countries and mainly affects infants and young children. It may be connected to an incomplete digestion of dietary proteins causing an inappropriate immune response in the gut. In order to study this, a biochemical model of infant gastroduodenal digestion has been developed, which has reduced levels of protease (eightfold for pepsin and tenfold for trypsin and chymotrypsin), phosphatidylcholine and bile salts, compared with the adult model. This model has been used to study the behaviour of three characterised food-relevant proteins (bovine [beta]-lactogl...
Source: Molecular Nutrition - November 20, 2009 Category: Nutrition Authors: Didier Dupont, Giuseppina Mandalari, Daniel Molle, Julien Jardin, Joëlle Léonil, Richard M. Faulks, Martin S. J. Wickham, E. N. Clare Mills, Alan R. Mackie Source Type: journals
Rapid, Sustained Improvement in Airflow With Budesonide/Formoterol for COPDEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Airways are opened within 5 minutes with budesonide/formoterol, and those improvements are sustained for at least 6 months in patients with chronic obstructive pulmonary disease (COPD). Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 19, 2009 Category: Consumer Health News Tags: allergy & Clinical Immunology Source Type: news
Nassau Candy Issues Nationwide Allergy Alert Because Of Possible Undeclared Allergens on their Tasty Dish Snack Tubs of Chocolate Almonds, Chocolate Raisins and Sour Neon WormsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Nassau Candy Distributors of Hicksville, New York, is voluntarily recalling possibly unlabeled pegable snack tubs because they contain the following undeclared allergens; Tree Nuts {Almonds}, Soy and Milk and may contain the following undeclared allergens Peanuts, other Tree Nuts {brazil nuts, walnuts, filberts, hazelnuts, pecans, pistachios, macadamia nuts, cashews and coconut}. People who have an allergy to any of these specific types of allergens run the risk of serious or life-threatening allergic reaction if they consume these products... (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 19, 2009 Category: Food Science Source Type: organizations
Olopatadine Nasal Spray Reduces Seasonal Allergy Symptoms in ChildrenEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Olopatadine hydrochloride 0.6% nasal spray, a nonsteroidal selective antihistamine, safely and effectively reduces ocular and nasal symptoms in children with seasonal allergic rhinitis. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 19, 2009 Category: Consumer Health News Tags: allergy & Clinical Immunology Source Type: news
A woman with acute myelopathy in pregnancy: case progressionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: BMJ Online First)
Source: BMJ Online First - November 19, 2009 Category: Journals (General) Authors: Reuss, R., Rommer, P. S, Bruck, W., Paul, F., Bolz, M., Jarius, S., Boettcher, T., Grossmann, A., Bock, A., Zipp, F., Benecke, R., Zettl, U. K Tags: Infectious diseases, Urology, Journalology, Haematology (incl blood transfusion), Immunology (including allergy), Multiple sclerosis, Spinal cord, Pregnancy, Reproductive medicine, Radiology, Clinical diagnostic tests, Urological surgery PRACTICE Source Type: journals
Opinions: Fighting TB; Currency Transaction TaxEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Innovation, Coordination Needed To 'Bring TB Research Into The 21st Century' Though tuberculosis "is one of the world's leading killers … few citizens, scientists and policymakers are demanding more attention to TB research, treatment and prevention. … It's time to bring TB research into the 21st century," Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, writes in an (Source: Public Health News From Medical News Today)
Source: Public Health News From Medical News Today - November 19, 2009 Category: Primary Care Tags: Tuberculosis Source Type: news
Have Egg Allergy? You May Still Be Candidate For Flu Vaccines, Says AllergistEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
As flu season got underway this fall, Dr. Catherine Monteleone, an allergist, noticed that her office started to receive an unusually high number of calls from people with egg allergy. They previously had avoided flu vaccines because of their sensitivity to eggs. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 19, 2009 Category: Consumer Health News Tags: Swine Flu Source Type: news
Have Egg Allergy? You May Still Be Candidate For Flu Vaccines, Says AllergistEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
As flu season got underway this fall, Dr. Catherine Monteleone, an allergist, noticed that her office started to receive an unusually high number of calls from people with egg allergy. They previously had avoided flu vaccines because of their sensitivity to eggs. This year, with all the attention being paid to the novel H1N1 influenza, those patients want to be protected against flu, and they contacted her to find out if they are candidates for inoculation. (Source: Allergy News From Medical News Today)
Source: Allergy News From Medical News Today - November 19, 2009 Category: Allergy & Immunology Tags: Swine Flu Source Type: news
New findings suggest strategy to help generate HIV-neutralizing antibodiesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(NIH/National Institute of Allergy and Infectious Diseases) New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 19, 2009 Category: Global & Universal Source Type: news
Sweet -- sugared polymer a new weapon against allergies and asthmaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Johns Hopkins Medical Institutions) Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks. Their advance is a significant step toward crafting pharmaceuticals to fight these often life-endangering conditions in a new way. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 19, 2009 Category: Global & Universal Source Type: news
UAB researchers discover antibody receptor identity, propose renaming immune-system geneEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(University of Alabama at Birmingham) In what has eluded discovery for 30 years, scientists have identified a cellular receptor for the immune system's first-response antibody immunoglobulin M (IgM). The proposed name is the Fc mu receptor gene; it describes a key region of the IgM antibody that binds this receptor and fills in a crucial gap in understanding the science behind immune deficiencies and allergy diseases, says UAB researchers. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 19, 2009 Category: Infectious Diseases Source Type: news
Nonstandardized Allergenic ProductsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Updated Date: Nov 19, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - November 19, 2009 Category: Drugs & Pharmacology Source Type: organizations
Allergenic Extracts For Diagnostic Use OnlyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Updated Date: Nov 19, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - November 19, 2009 Category: Drugs & Pharmacology Source Type: organizations
Advances in Allergen-Specific Immunotherapy.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
After several decades of controversies, allergen specific immunotherapy (SIT) was recognized as an effective treatment for respiratory and hymenoptera allergy by the World Health Organization in 1998. SIT involves the administration (usually subcutaneous) of increasing doses of allergen in order to achieve a hyposensitization. Moreover, SIT is the only allergen-specific treatment capable of modifying the natural history of the disease. During the last 25 years, there was an impressive development of basic and clinical research in the field of SIT, with the goal of improving the safety, the efficacy and ameliorating the...
Source: Current Drug Targets - November 19, 2009 Category: Drugs & Pharmacology Authors: Passalacqua G, Compalati E, Canonica GW Tags: Curr Drug Targets Source Type: journals
Acute abdomenEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: BMJ Online First)
Source: BMJ Online First - November 19, 2009 Category: Journals (General) Tags: Neurogastroenterology, Pancreas and biliary tract, Infectious diseases, Small intestine, Immunology (including allergy), Drugs: cardiovascular system, Pain (neurology), Stroke, Inflammation, Trauma, Arrhythmias, Injury ENDGAMES Source Type: journals
